Skip to main navigation Skip to search Skip to main content

Atherosclerotic and Cardio-Metabolic Diseases: From Molecular Basis to Therapeutic Advances

  • Eva Kassi
  • , Ioannis Kyrou
  • , Harpal S. Randeva
  • Unit of Molecular Endocrinology, Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens,11527 Athens, Greece; Endocrine Oncology Unit, 1st Department of Propaedeutic Internal Medicine, Laiko Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece
  • Warwickshire Institute for the Study of Diabetes, Endocrinology and Metabolism (WISDEM) and Human Metabolism Research Unit (HMRU), University Hospitals Coventry and Warwickshire NHS Trust, Coventry, CV2 2DX, UK.

Research output: Contribution to journalEditorialpeer-review

3   Link opens in a new tab Citations (SciVal)
14 Downloads (Pure)

Abstract

Cardiovascular diseases (CVDs) still remain the major cause of death worldwide; however, CVD-related mortality has been reduced due to lifestyle modification interventions, as well as novel pharmacological therapies and advances in cardiovascular surgery [...]
Original languageEnglish
Article number9737
Number of pages6
JournalInternational Journal of Molecular Sciences
Volume24
Issue number11
Early online date4 Jun 2023
DOIs
Publication statusPublished - 4 Jun 2023

Bibliographical note

Copyright © 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Keywords

  • Inorganic Chemistry
  • Organic Chemistry
  • Physical and Theoretical Chemistry
  • Computer Science Applications
  • Spectroscopy
  • Molecular Biology
  • General Medicine
  • Catalysis

Fingerprint

Dive into the research topics of 'Atherosclerotic and Cardio-Metabolic Diseases: From Molecular Basis to Therapeutic Advances'. Together they form a unique fingerprint.

Cite this